tldrdaily.news logo
Tag

Naion

All articles tagged with #naion

law-and-health4 months ago

Ozempic and GLP-1 Drugs: Risks, Trends, and Effectiveness in Weight Loss

Ozempic, a popular drug for weight loss and diabetes, is facing numerous lawsuits due to alleged severe side effects, especially irreversible vision loss from NAION, with regulatory bodies and studies supporting a potential link. The legal battle is intensifying, with significant financial and reputational risks for Novo Nordisk, as plaintiffs share personal stories and courts consider the evidence. The outcome could reshape pharmaceutical accountability and drug safety standards.

via Bored Panda|
#law-and-health#lawsuit#naion
health4 months ago

Rare Vision Loss Risks Linked to Popular Diabetes and Weight Loss Drugs

A Maryland man claims that the popular diabetes and weight loss drug Ozempic caused his sudden, irreversible blindness due to a rare condition called NAION, raising concerns about the drug's safety and the need for clearer warnings. Emerging research and regulatory reviews are investigating the potential link between semaglutide medications and this serious side effect.

via WJLA|
#blindness#diabetes#health
health4 months ago

Risks of Vision Loss Linked to GLP-1 Diabetes Drugs

Recent studies on semaglutide, a GLP-1 medication, show conflicting results regarding its link to eye problems. While some research suggests a possible association with nonarteritic anterior ischemic optic neuropathy (NAION), overall evidence is inconclusive, and the medication appears not to significantly increase the risk of diabetic retinopathy or other eye disorders. Experts recommend ongoing research and regular eye exams for users.

via Medical News Today|
#diabetic-retinopathy#eye-problems#health
health5 months ago

Weight-Loss Drugs and Eye Health: What You Need to Know

Recent studies suggest that GLP-1 agonist drugs like Ozempic and Wegovy, used for weight loss and diabetes management, may carry a small risk of serious eye conditions such as NAION and diabetic retinopathy, but the overall risk appears modest and requires further research. Patients with risk factors should consult their doctors and undergo regular eye exams to monitor eye health while on these medications.

via ScienceAlert|
#diabetic-retinopathy#glp-1-agonists#health
health5 months ago

Weight-loss and Diabetes Drugs Associated with Rare Eye Conditions and Vision Risks

Recent studies suggest that GLP-1 agonists like Ozempic and Wegovy may slightly increase the risk of serious eye conditions such as NAION and diabetic retinopathy, but they also offer significant benefits for managing diabetes and obesity. Regular eye exams and careful risk assessment are recommended for users, especially those with pre-existing risk factors. Ongoing research aims to better understand these risks and improve patient safety.

via The Conversation|
#diabetic-retinopathy#eye-conditions#health
health1 year ago

Study Links Ozempic to Vision Loss Risk, Novo Nordisk Shares Fall

A non-peer reviewed study suggests a potential link between Novo Nordisk's diabetes drug Ozempic and an increased risk of developing NAION, a rare eye condition causing sudden blindness. The study found that Ozempic users were over twice as likely to develop NAION compared to those on other diabetes medications, though the overall incidence remains low. The findings highlight the need to balance the drug's benefits in managing diabetes and obesity against the potential risk of vision loss.

via Quartz|
#diabetes#health#naion
health1 year ago

Study Confirms Rare Vision Loss Risk with Ozempic

A study has linked Novo Nordisk's diabetes drug Ozempic to an increased risk of a rare vision loss condition called NAION, confirming earlier Harvard research. The study found that diabetes patients using Ozempic were more than twice as likely to develop NAION compared to those on other diabetes medications. Although the overall risk remains low, the condition is irreversible and potentially blinding. Novo Nordisk maintains that the drug's benefits outweigh the risks, as few NAION cases were observed in their trials. The findings have impacted Novo's stock, which fell by 5.4% in Copenhagen.

via Yahoo Finance|
#diabetes#health#naion
health1 year ago

Study Confirms Rare Vision Loss Risk with Ozempic

A study has confirmed that the diabetes medication Ozempic, produced by Novo Nordisk, is linked to an increased risk of a rare vision loss condition known as NAION. The research, which analyzed patient records from Denmark and Norway, found that diabetes patients using Ozempic were more than twice as likely to develop NAION compared to those on other diabetes medications. The study did not assess the impact of Wegovy, a related drug used for obesity.

via Bloomberg|
#diabetes#health#naion